Long-Term Outcomes of ATG versus IL-2 Receptor Antagonist in Low Risk Kidney Transplant Recipients: Donor Factors.F. Al Ammary,S. Bae,A. Massie,N. Desai,N. Dagher,E. Kraus,A. Wiseman,D. SegevAMERICAN JOURNAL OF TRANSPLANTATION(2016)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要